Individual Approaches to Diagnosis and Treatment of Epilepsia (Review)

Epilepsy is one of the most common and treatment-resistant neurological diseases; it has heterogenic manifestations and requires individual approaches to its diagnosis and treatment. The ground for such approaches has been laid by modern science-based technologies, currently available in clinical practice. The aim of this review is to analyze publications on personalized approaches to the diagnosis and treatment of epilepsy over the past 10 years. In this review, we discuss the issue of individual markers of epilepsy and their predictive power, new approaches to localizing the epileptic foci, the relationship between the left-sided, right-sided and interhemispheric asymmetry and epileptogenesis, the role of comorbid disorders in epilepsy, as well as the available options for identifying the predictors of treatment efficacy.

1. Melikyan E.G., Milchakova L.E., Guekht A.B., Gusev E.I. Quality of life in epileptology. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2008; 108(Suppl 3): 28–35.
2. Melikyan E.G., Gekht A.B. Life quality in epileptic patients. Lechebnoe delo 2011; 1: 1–9.
3. Duncan S., Brodie M.J. Sudden unexpected death in epilepsy. Epilepsy Behav 2011; 21(4): 344–351, https://doi.org/10.1016/j.yebeh.2011.04.056.
4. Shorvon S., Tomson T. Sudden unexpected death in epilepsy. Lancet 2011; 378(9808): 2028–2038, https://doi.org/10.1016/s0140-6736(11)60176-1.
5. Duble S.N., Thomas S.V. Sudden unexpected death in epilepsy. Indian J Med Res 2017; 145(6): 738–745, https://doi.org/10.4103/ijmr.ijmr_548_17.
6. Guerreiro C.A. Epilepsy: is there hope? Indian J Med Res 2016; 144(5): 657–660, https://doi.org/10.4103/ijmr.ijmr_1051_16.
7. Rizvi S., Ladino L.D., Hernandez-Ronquillo L., Téllez-Zenteno J.F. Epidemiology of early stages of epilepsy: risk of seizure recurrence after a first seizure. Seizure 2017; 49: 46–53, https://doi.org/10.1016/j.seizure.2017.02.006.
8. Avakyan G.G., Voronina T.A., Litvinova S.A., Nerobkova L.N., Balabanyan V.U., Nikonova A.A., Avakyan G.N. New approaches in the treatment of epilepsy. Annaly kliniceskoj i eksperimental’noj nevrologii 2017; 11(3): 15–22.
9. Tang F., Hartz A.M.S., Bauer B. Drug-resistant epilepsy: multiple hypotheses, few answers. Front Neurol 2017; 8: 301, https://doi.org/10.3389/fneur.2017.00301.
10. Jensen F.E. Epilepsy as a spectrum disorder: implications from novel clinical and basic neuroscience. Epilepsia 2011; 52(Suppl 1): 1–6, https://doi.org/10.1111/j.1528-1167.2010.02904.x.
11. Syvertsen M.R., Thuve S., Stordrange B.S., Brodtkorb E. Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years. Seizure 2014; 23(5): 344–348, https://doi.org/10.1016/j.seizure.2014.01.012.
12. Zorin R.A., Zhadnov V.A., Lapkin M.M. The heterogeneity of patients with epilepsy in terms of psychological characteristics, quality of life, and a response to anticonvulsant therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika 2017; 9(1S): 58–63, https://doi.org/10.14412/2074-2711-2017-1s-58-63.
13. Pisani L.R., Nikanorova M., Landmark C.J., Johannessen S.I., Pisani F. Specific patient features affect antiepileptic drug therapy decisions. Focus on gender, age, and psychiatric comorbidities. Curr Pharm Res 2017; 23(37): 5639–5648, https://doi.org/10.2174/1381612823666170926103631.
14. Veldiaksova E.D., Yakunina A.V., Pisar A.A. Modern capabilities of personalized prescription antiepileptic drugs. Zdorov’e i obrazovanie v XXI veke 2017; 19(4): 56–61.
15. Pitkänen A., Löscher W., Vezzani A., Becker A.J., Simonato M., Lukasiuk K., Gröhn O., Bankstahl J.P., Friedman A., Aronica E., Gorter J.A., Ravizza T., Sisodiya S.M., Kokaia M., Beck H. Advances in the development of biomarkers for epilepsy. Lancet Neurol 2016; 15(8): 843–856, https://doi.org/10.1016/s1474-4422(16)00112-5.
16. Vezzani A., Pascente R., Ravizza T. Biomarkers of epileptogenesis: the focus on glia and cognitive dysfunctions. Neurochem Res 2017; 42(7): 2089–2098, https://doi.org/10.1007/s11064-017-2271-3.
17. van Dijkman S.C., Voskuyl R.A., de Lange E.C. Biomarkers in epilepsy — a modelling perspective. Eur J Pharm Sci 2017; 109S: S47–S52, https://doi.org/10.1016/j.ejps.2017.05.035.
18. Beghi E., Giussani G., Sander J.W. The natural history and prognosis of epilepsy. Epileptic Disord 2015; 17(3): 243–253.
19. Kerr E.N., Fayed N. Cognitive predictors of adaptive functioning in children with symptomatic epilepsy. Epilepsy Res 2017; 136: 67–76, https://doi.org/10.1016/j.eplepsyres.2017.07.015.
20. Silva I., Lin K., Jackowski A.P., Centeno Rda S., Pinto M.L., Carrete H. Jr., Yacubian E.M., Amado D. Absence of gender effect on amygdala volume in temporal lobe epilepsy. Epilepsy Behav 2010; 19(3): 501–503, https://doi.org/10.1016/j.yebeh.2010.08.031.
21. Kemmotsu N., Girard H.M., Bernhardt B.C., Bonilha L., Lin J.J., Tecoma E.S., Iragui V.J., Hagler D.J. Jr., Halgren E., McDonald C.R. MRI analysis in temporal lobe epilepsy: cortical thinning and white matter disruptions are related to side of seizure onset. Epilepsia 2011; 52(12): 2257–2266, https://doi.org/10.1111/j.1528-1167.2011.03278.x.
22. Santana M.T., Jackowski A.P., da Silva H.H., Caboclo L.O., Centeno R.S., Bressan R.A., Carrete H. Jr., Yacubian E.M. Auras and clinical features in temporal lobe epilepsy: a new approach on the basis of voxel-based morphometry. Epilepsy Res 2010; 89(2–3): 327–338, https://doi.org/10.1016/j.eplepsyres.2010.02.006.
23. Middlebrooks E.H., Ver Hoef L., Szaflarski J.P. Neuroimaging in еpilepsy. Curr Neurol Neurosci Rep 2017; 17(4): 32, https://doi.org/10.1007/s11910-017-0746-x.
24. Trimmel K., Sachsenweger J., Lindinger G., Auff E., Zimprich F., Pataraia E. Lateralization of language function in epilepsy patients: a high-density scalp-derived event-related potentials (ERP) study. Clin Neurophysiol 2017; 128(3): 472–479, https://doi.org/10.1016/j.clinph.2016.12.025.
25. Tailby C., Abbott D.F., Jackson G.D. The diminishing dominance of the dominant hemisphere: language fMRI in focal epilepsy. Neuroimage Clin 2017; 14: 141–150, https://doi.org/10.1016/j.nicl.2017.01.011.
26. Kalamangalam G.P., Tandon N., Saria H.Y., Slater J.D. Asymmetric scalp electromyogram: a common and accurate lateralizing sign in motor seizures. J Clin Neurophysiol 2011; 28(5): 512–519, https://doi.org/10.1097/wnp.0b013e318231c01f.
27. Mirzadjanova Z., Peters A.S., Rémi J., Bilgin C., Silva Cunha J.P., Noachtar S. Significance of lateralization of upper limb automatisms in temporal lobe epilepsy: a quantitative movement analysis. Epilepsia 2010; 51(10): 2140–2146, https://doi.org/10.1111/j.1528-1167.2010.02599.x.
28. Rémi J., Cunha J.P., Vollmar C., Topçuoğlu Ö.B., Meier A., Ulowetz S., Beleza P., Noachtar S. Quantitative movement analysis differentiates focal seizures characterized by automatisms. Epilepsy Behav 2011; 20(4): 642–647, https://doi.org/10.1016/j.yebeh.2011.01.020.
29. Foldvary-Schaefer N., Unnwongse K. Localizing and lateralizing features of auras and seizures. Epilepsy Behav 2011; 20(2): 160–166, https://doi.org/10.1016/j.yebeh.2010.08.034.
30. Peters A.S., Rémi J., Vollmar C., Gonzalez-Victores J.A., Cunha J.P., Noachtar S. Dysprosody during epileptic seizures lateralizes to the nondominant hemisphere. Neurology 2011; 77(15): 1482–1486, https://doi.org/10.1212/wnl.0b013e318232abae.
31. Bauer G., Broessner G., Unterberger I., Walser G., Pfausler B., Trinka E. Head turning as a prominent motor symptom in status epilepticus. Epileptic Disord 2008; 10(2): 119–129.
32. Rémi J., Wagner P., O’Dwyer R., Silva Cunha J.P., Vollmar C., Krotofil I., Noachtar S. Ictal head turning in frontal and temporal lobe epilepsy. Epilepsia 2011; 52(8): 1447–1451, https://doi.org/10.1111/j.1528-1167.2011.03076.x.
33. Fernandes M.A., Smith M.L., Logan W., Crawley A., McAndrews M.P. Comparing language lateralization determined by dichotic listening and fMRI activation in frontal and temporal lobes in children with epilepsy. Brain Lang 2006; 96(1): 106–114, https://doi.org/10.1016/j.bandl.2005.06.006.
34. Bedoin N., Ferragne E., Lopez C., Herbillon V., De Bellescize J., des Portes V. Atypical hemispheric asymmetries for the processing of phonological features in children with rolandic epilepsy. Epilepsy Behav 2011; 21(1): 42–51, https://doi.org/10.1016/j.yebeh.2011.02.026.
35. Carlsson G., Wiegand G., Stephani U. Interictal and postictal performances on dichotic listening test in children with focal epilepsy. Brain Cogn 2011; 76(2): 310–315, https://doi.org/10.1016/j.bandc.2011.03.014.
36. Zaidi Z.F. Body asymmetries: incidence, etiology and clinical implications. Australian Journal of Basic and Applied Sciences 2011; 5(9): 2157–2191.
37. Chuprikov A.P. Mir levorukikh [The world of lefthanders]. Kiev: Institut neyropsikhiatrii A. Chuprikova, 2008.
38. Slezicki K.I., Cho Y.W., Yi S.D., Brock M.S., Pfeiffer M.H., McVearry K.M., Tractenberg R.E., Motamedi G.K. Incidence of atypical handedness in epilepsy and its association with clinical factors. Epilepsy Behav 2009; 16(2): 330–334, https://doi.org/10.1016/j.yebeh.2009.08.006.
39. Stewart C.C., Swanson S.J., Sabsevitz D.S., Rozman M.E., Janecek J.K., Binder J.R. Predictors of language lateralization in temporal lobe epilepsy. Neuropsychologia 2014; 60: 93–102, https://doi.org/10.1016/j.neuropsychologia.2014.05.021.
40. Doležalová I., Schachter S., Chrastina J., Hemza J., Hermanová M., Rektor I., Pažourková M., Brázdil M. Atypical handedness in mesial temporal lobe epilepsy. Epilepsy Behav 2017; 72: 78–81, https://doi.org/10.1016/j.yebeh.2017.01.034.
41. Kalinin V.V., Zemlyanaya A.A., Krylov O.E., Zheleznova E.V. Handedness, alexithymia, and focus laterality as risk factors for psychiatric comorbidity in patients with epilepsy. Epilepsy Behav 2010; 17(3): 389–394, https://doi.org/10.1016/j.yebeh.2009.12.028.
42. Lin J.J., Riley J.D., Juranek J., Cramer S.C. Vulnerability of the frontal-temporal connections in temporal lobe epilepsy. Epilepsy Res 2008; 82(2–3): 162–170, https://doi.org/10.1016/j.eplepsyres.2008.07.020.
43. Riley J.D., Franklin D.L., Choi V., Kim R.C., Binder D.K., Cramer S.C., Lin J.J. Altered white matter integrity in temporal lobe epilepsy: association with cognitive and clinical profiles. Epilepsia 2010; 51(4): 536–545, https://doi.org/10.1111/j.1528-1167.2009.02508.x.
44. Ung H., Cazares C., Nanivadekar A., Kini L., Wagenaar J., Becker D., Krieger A., Lucas T., Litt B., Davis K.A. Interictal epileptiform activity outside the seizure onset zone impacts cognition. Brain 2017; 140(8): 2157–2168, https://doi.org/10.1093/brain/awx143.
45. Caplan R., Siddarth P., Stahl L., Lanphier E., Vona P., Gurbani S., Koh S., Sankar R., Shields W.D. Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities. Epilepsia 2008; 49(11): 1838–1846, https://doi.org/10.1111/j.1528-1167.2008.01680.x.
46. Rzezak P., Valente K.D., Duchowny M.S. Temporal lobe epilepsy in children: executive and mnestic impairments. Epilepsy Behav 2014; 31: 117–122, https://doi.org/10.1016/j.yebeh.2013.12.005.
47. Kanner A.M. Psychiatric comorbidities in new onset epilepsy: should they be always investigated? Seizure 2017; 49: 79–82, https://doi.org/10.1016/j.seizure.2017.04.007.
48. Helmstaedter C., Witt J.A. Epilepsy and cognition — a bidirectional relationship? Seizure 2017; 49: 83–89, https://doi.org/10.1016/j.seizure.2017.02.017.
49. Melikyan E.G., Guekht A.B. Effect of comorbidity on quality of life of patients with epilepsy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2011; 111(1): 91–97.
50. Kerr M.P., Mensah S., Besag F., de Toffol B., Ettinger A., Kanemoto K., Kanner A., Kemp S., Krishnamoorthy E., LaFrance W.C. Jr., Mula M., Schmitz B., van Elst L.T., Trollor J., Wilson S.J. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011; 52(11): 2133–2138, https://doi.org/10.1111/j.1528-1167.2011.03276.x.
51. Mula M. Depression in epilepsy. Curr Opin Neurol 2017; 30(2): 180–186, https://doi.org/10.1097/wco.0000000000000431.
52. Elger C.E., Johnston S.A., Hoppe C. Diagnosing and treating depression in epilepsy. Seizure 2017; 44: 184–193, https://doi.org/10.1016/j.seizure.2016.10.018.
53. Bruder G.E., Tenke C.E., Warner V., Weissman M.M. Grandchildren at high and low risk for depression differ in EEG measures of regional brain asymmetry. Biol Psychiatry 2007; 62(11): 1317–1323, https://doi.org/10.1016/j.biopsych.Э2006.12.006.
54. Nusslock R., Shackman A.J., Harmon-Jones E., Alloy L.B., Coan J.A., Abramson L.Y. Cognitive vulnerability and frontal brain asymmetry: common predictors of first prospective depressive episode. J Abnorm Psychol 2011: 120(2): 497–503, https://doi.org/10.1037/a0022940.
55. Gandy M., Sharpe L., Perry K.N., Miller L., Thayer Z., Boserio J., Mohamed A. Anxiety in epilepsy: a neglected disorder. J Psychosom Res 2015; 78(2): 149–155, https://doi.org/10.1016/j.jpsychores.2014.12.002.
56. Loney J.C., Wirrell E.C., Sherman E.M., Hamiwka L.D. Anxiety and depressive symptoms in children presenting with a first seizure. Pediatr Neurol 2008; 39(4): 236–240, https://doi.org/10.1016/j.pediatrneurol.2008.07.005.
57. Ekinci O., Titus J.B., Rodopman A.A., Berkem M., Trevathan E. Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment. Epilepsy Behav 2009; 14(1): 8–18, https://doi.org/10.1016/j.yebeh.2008.08.015.
58. Kanner A.M., Trimble M., Schmitz B. Postictal affective episodes. Epilepsy Behav 2010; 19(2): 156–158, https://doi.org/10.1016/j.yebeh.2010.06.024.
59. Reilly C., Agnew R., Neville B.G. Depression and anxiety in childhood epilepsy: a review. Seizure 2011; 20(8): 589–597, https://doi.org/10.1016/j.seizure.2011.06.004.
60. Kotov A.S. Anxiety in epileptic patients. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2013; 112(4–2): 41–44.
61. Hecimovic H., Salpekar J., Kanner A.M., Barry J.J. Suicidality and epilepsy: a neuropsychobiological perspective. Epilepsy Behav 2011; 22(1): 77–84, https://doi.org/10.1016/j.yebeh.2011.04.059.
62. Caplan R., Siddarth P., Levitt J., Gurbani S., Shields W.D., Sankar R. Suicidality and brain volumes in pediatric epilepsy. Epilepsy Behav 2010; 18(3): 286–290, https://doi.org/10.1016/j.yebeh.2010.04.018.
63. Dinkelacker V., Xin X., Baulac M., Samson S., Dupont S. Interictal epileptic discharge correlates with global and frontal cognitive dysfunction in temporal lobe epilepsy. Epilepsy Behav 2016; 62: 197–203, https://doi.org/10.1016/j.yebeh.2016.07.009.
64. Holmes G.L. Cognitive impairment in epilepsy: the role of network abnormalities. Epileptic Disord 2015; 17(2): 101–116.
65. Turovskaya N.G. Epilepsy and psychic developmental disorders: a literature review. Teoreticheskaya i eksperimentalnaya psikhologiya 2016; 9(3): 40–53.
66. Bell B., Lin J.J., Seidenberg M., Hermann B. The neurobiology of cognitive disorders in temporal lobe epilepsy. Nat Rev Neurol 2011; 7(3): 154–164, https://doi.org/10.1038/nrneurol.2011.3.
67. Gauffin H., Flensner G., Landtblom A.M. Living with epilepsy accompanied by cognitive difficulties: young adults’ experiences. Epilepsy Behav 2011; 22(4): 750–758, https://doi.org/10.1016/j.yebeh.2011.09.007.
68. Alfstad K.Å., Torgersen H., Van Roy B., Hessen E., Hansen B.H., Henning O., Clench-Aas J., Mowinckel P., Gjerstad L., Lossius M.I. Psychiatric comorbidity in children and youth with epilepsy: an association with executive dysfunction? Epilepsy Behav 2016; 56: 88–94, https://doi.org/10.1016/j.yebeh.2016.01.007.
69. Sepeta L.N., Casaletto K.B., Terwilliger V., Facella-Ervolini J., Sady M., Mayo J., Gaillard W.D., Berl M.M. The role of executive functioning in memory performance in pediatric focal epilepsy. Epilepsia 2017; 58(2): 300–310, https://doi.org/10.1111/epi.13637.
70. Guzeva V.I., Belash V.O., Guzeva V.V., Guzeva O.V., Okembra Ibarra E.A. Peculiarities of cognitive functions in children with epilepsy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2008; 108(9): 24–28.
71. Nickels K.C., Zaccariello M.J., Hamiwka L.D., Wirrell E.C. Cognitive and neurodevelopmental comorbidities in paediatric epilepsy. Nat Rev Neurol 2016; 12(8): 465–476, https://doi.org/10.1038/nrneurol.2016.98.
72. Tolstova N.V., Kotov S.V., Kotov A.S. Cognitive functions in patients with idiopathic generalized and cryptogenic focal epilepsy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2010; 110(10): 8–13.
73. Miller L.A., Galioto R., Tremont G., Davis J., Bryant K., Roth J., LaFrance W.C. Jr., Blum A.S. Cognitive impairment in older adults with epilepsy: characterization and risk factor analysis. Epilepsy Behav 2016; 56: 113–117, https://doi.org/10.1016/j.yebeh.2016.01.011.
74. Brooks-Kayal A. Molecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children. Epilepsia 2011; 52(Suppl 1): 13–20, https://doi.org/10.1111/j.1528-1167.2010.02906.x.
75. Shomakhova M.M., Lebedeva A.V., Ershov A.V., Khomutov V.E., Gudkova A.A. Predictors of cognitive disturbances in epilepsy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2011; 111(5–2): 65–71.
76. Baca C.B., Vickrey B.G., Caplan R., Vassar S.D., Berg A.T. Psychiatric and medical comorbidity and quality of life outcomes in childhood-onset epilepsy. Pediatrics 2011; 128(6): e1532–e1543, https://doi.org/10.1542/peds.2011-0245.
77. Karouni M., Arulthas S., Larsson P.G., Rytter E., Johannessen S.I., Landmark C.J. Psychiatric comorbidity in patients with epilepsy: a population-based study. Eur J Clin Pharmacol 2010; 66(11): 1151–1160, https://doi.org/10.1007/s00228-010-0861-y.
78. Voronkova K.V., Pylaeva O.A., Kholin A.A., Kosyakova E.S., Mazalskaya O.V., Koroleva N.Yu., Akhmedov T.M., Buchneva I.A., Petrukhin A.S. Side effects of antiepileptic therapy — modern state of the problem. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2011; 111(10–2): 44–51.
79. Kovaleva I.J. Adverse effects of antiepileptic drugs. Epilepsiya i paroksizmalnye sostoyaniya 2017; 9(1): 51–61.
80. Irwin L.G., Fortune D.G. Risk factors for psychosis secondary to temporal lobe epilepsy: a systematic review. J Neuropsychiatry Clin Neurosci 2014; 26(1): 5–23, https://doi.org/10.1176/appi.neuropsych.12120403.
81. Karlov V.A. Pharmacoresistance and tolerability in epilepsy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2008; 108(10): 75–81.
82. Hitiris N., Mohanraj R., Norrie J., Sills G.J., Brodie M.J. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007; 75(2–3): 192–196, https://doi.org/10.1016/j.eplepsyres.2007.06.003.
83. Kanner A.M. Is depression a risk factor of worse response to therapy in epilepsy? Epilepsy Curr 2011; 11(2): 50–51, https://doi.org/10.5698/1535-7511-11.2.50.
84. Elger C.E., Hoppe C. What is depression in epilepsy? Front Neurol 2011; 2: 79, https://doi.org/10.3389/fneur.2011.00079.
85. Wirrell E.C. Predicting pharmacoresistance in pediatric epilepsy. Epilepsia 2013; 54(Suppl 2): 19–22, https://doi.org/10.1111/epi.12179.
86. Russo A., Posar A., Conti S., Parmeggiani A. Prognostic factors of drug-resistant epilepsy in childhood: an Italian study. Pediatr Int 2015; 57(6): 1143–1148, https://doi.org/10.1111/ped.12705.
87. Kotov A.S. Predictors of pharmacoresistance in adults with epilepsy. Annaly klinicheskoy i eksperimentalnoy nevrologii 2012; 6(1): 25–30.
88. Karlov V.A., Guekht A.B., Guzeva V.I., Lipatova L.V., Bazilevich S.N., Mkrtchyan V.R., Vlasov P.N., Zhidkova I.A., Mukhin K.Y., Petrukhin A.S., Lebedeva A.V. Algorithms of mono- and polytherapy in clinical epileptology. Part 1. General principles of drug choice. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2016; 116(6): 109–114, https://doi.org/10.17116/jnevro201611661109-114.
89. Mula M. Epilepsy and psychiatric comorbidities: drug selection. Curr Treat Options Neurol 2017; 19(12): 44, https://doi.org/10.1007/s11940-017-0483-0.
90. Zemlyanaya A.A., Kalinin V.V., Zheleznova E.V., Sokolova L.V. The changes in cognitive impairment in patients with epilepsy during the disease course (on example of executive functions). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2016; 116(9–2): 25–31, https://doi.org/10.17116/jnevro20161169225-31.
91. Kalinin V.V., Zemlyanaya A.A., Krylov O.E. Clinical characteristics and therapeutic dynamics in epilepsy with regard for functional brain organization. Sotsialnaya i klinicheskaya psikhiatriya 2010; 20(3): 26–33.
92. Zemlianaia A.A., Kalinin V.V., Zheleznova E.V., Sokolova L.V. Personality and neurobiological factors as predictors of treatment efficacy in patients with partial epilepsy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2012; 112(6–2): 72–77.
93. Zemlianaia A.A., Kalinin V.V. Epilepsiya i mezhpolusharnaya asimmetriya mozga. neyropsikhiatricheskie aspekty [Epilepsy and hemispheric asymmetry of the brain. Neuropsykhiatric aspects]. Saarbrucken: LAP Lambert Academic Publishing; 2012.
94. Zemlianaia A.A., Kalinin V.V. Influence of hemispheric asymmetry of the brain on the prognosis of the efficacy of antiseizure therapy in patients with pharmacoresistive epilepsy. Eksperimentalnaya i klinicheskaya farmakologiya 2015; 78(3, Suppl): 25–29.
95. Mohd-Tahir N.A., Li S.C. Meta-analyses of newer antiepileptic drugs as adjunct for treatment of focal epilepsy in children. Epilepsy Res 2017; 139: 113–122, https://doi.org/10.1016/j.eplepsyres.2017.11.007.
96. Shih J.J., Whitlock J.B., Chimato N., Vargas E., Karceski S.C., Frank R.D. Epilepsy treatment in adults and adolescents: expert opinion, 2016. Epilepsy Behav 2017; 69: 186–222, https://doi.org/10.1016/j.yebeh.2016.11.018.
97. Kopylov F.U., Sokolova A.A., Lebedev G.S., Suchkov S.V., Chomakhidze P.S. Future development institute of precision medicine: new horizons of education and clinical activity. Meditsinskoe obrazovanie i vuzovskaya nauka 2017; 2(10): 12–17.
98. Rosenow F., van Alphen N., Becker A., Chiocchetti A., Deichmann R., Deller T., Freiman T., Freitag C.M., Gehrig J., Hermsen A.M., Jedlicka P., Kell C., Klein K.M., Knake S., Kullmann D.M., Liebner S., Norwood B.A., Omigie D., Plate K., Reif A., Reif P.S., Reiss Y., Roeper J., Ronellenfitsch M.W., Schorge S., Schratt G., Schwarzacher S.W., Steinbach J.P., Strzelczyk A., Triesch J., Wagner M., Walker M.C., von Wegner F., Bauer S. Personalized translational epilepsy research — novel approaches and future perspectives: Part I: clinical and network analysis approaches. Epilepsy Behav 2017; 76: 13–18, https://doi.org/10.1016/j.yebeh.2017.06.041.
99. Bauer S., van Alphen N., Becker A., Chiocchetti A., Deichmann R., Deller T., Freiman T., Freitag C.M., Gehrig J., Hermsen A.M., Jedlicka P., Kell C., Klein K.M., Knake S., Kullmann D.M., Liebner S., Norwood B.A., Omigie D., Plate K., Reif A., Reif P.S., Reiss Y., Roeper J., Ronellenfitsch M.W., Schorge S., Schratt G., Schwarzacher S.W., Steinbach J.P., Strzelczyk A., Triesch J., Wagner M., Walker M.C., von Wegner F., Rosenow F. Personalized translational epilepsy research — novel approaches and future perspectives: Part II: experimental and translational approaches. Epilepsy Behav 2017; 76: 7–12, https://doi.org/10.1016/j.yebeh.2017.06.040.
100. Fedotchev А.I., Parin S.B., Polevaya S.A., Velikova S.D. Brain-computer interface and neurofeedback technologies: current state, problems and clinical prospects (review). Sovremennye tehnologii v medicine 2017; 9(1): 175–184, https://doi.org/10.17691/stm2017.9.1.22.
101. Zemlyanaya A.A., Fedotcheva T.A., Fedotchev A.I. Modern approaches to human cognitive activity enhancement. Uspekhi fiziologicheskikh nauk 2010; 41(4): 45–62.
102. Fedotchev A.I., Zemlyanaya A.A., Polevaya S.A., Savchuk L.V. Attention deficit hyperactivity disorder and current possibilities of its treatment by the method of neurofeedback training. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2016; 116(5): 98–101, https://doi.org/10.17116/jnevro20161165198-101.
103. Fedotchev A., Radchenko G., Zemlianaia A. On one approach to health protection: music of the brain. J Integr Neurosci 2017, https://doi.org/10.3233/jin-170053. [Epub ahead of print]

Zemlyanaya A.A., Fedotchev A.I. Individual Approaches to Diagnosis and Treatment of Epilepsia (Review). Sovremennye tehnologii v medicine 2018; 10(3): 204, https://doi.org/10.17691/stm2018.10.3.25